PCSA
PCSA
NASDAQ · Pharmaceuticals

Processa Pharmaceuticals Inc

$1.93
+0.09 (+4.89%)
As of Nov 7, 2:52 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,811.9% upside
Low Target $23.79
Average Target $36.90
High Target $41.20
Current Price $1.93
Current
$1.93
Target
$36.90
$23.79 $36.90 avg $41.20
Scenario Analysis
Bear Case
$23.79
1,132.6%
Low target
Base Case
$36.90
+1,811.9%
Avg target
Bull Case
$41.20
+2,034.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.00
-78.6% from high
52-Week Low
$1.04
+85.4% from low
Target vs 52W High
$36.90
+310.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%